A Phase 1 Study Of Tp-3654, An Oral Pim Kinase Inhibitor, In Patients With Intermediate-2 Or High-Risk Primary Or Secondary Myelofibrosis
TP-3654
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1 Study Of Tp-3654, An Oral Pim Kinase Inhibitor, In Patients With Intermediate-2 Or High-Risk Primary Or Secondary Myelofibrosis ### Output: TP-3654